Protocol No.: S2302

Title
PRAGMATICA - LUNG: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) Plus Pembrolizumab (MK-3475; NSC 776864) Versus Standard of Care for Participants Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer
Principal Investigator
Almubarak, Mohammed
Phase
III
Age Group
Adult
Applicable Disease Site
Lung Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contacts
Carla Ross, RN
Senior Research Nurse
Phone: +1 304-293-2633
Maher Kali, MD
Clinical Research Specialist
Phone: +1 304-243-7045
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Nnennaya Opara
Clinical Research Specialist
Phone: +1 681-342-1000

View on ClinicalTrials.gov